Siliq FDA Approval History
FDA Approved: Yes (First approved February 15, 2017)
Brand name: Siliq
Generic name: brodalumab
Dosage form: Injection
Company: Bausch Health Companies Inc.
Treatment for: Plaque Psoriasis
Siliq (brodalumab) is a human anti-interleukin-17-receptor monoclonal antibody for the treatment of plaque psoriasis.
Development timeline for Siliq
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.